Morning Briefing
Summaries of health policy coverage from major news organizations
Research Roundup: The Latest Science, Discoveries, And Breakthroughs
The Washington Post: A New Thumb Implant Promises Improved Function For People With Arthritis
For advanced arthritis, the most common treatment is a trapeziectomy. This involves removing the trapezium, a small bone at the base of your thumb, near your wrist. While it tends to be overall effective, it comes with some cons, too. A new medical device that was approved in 2025 is giving hand surgeons an alternative way to fix thumb arthritis that could cut recovery time and improve function. (Carter, 11/15)
MedPage Today: FDA OKs Drug Linked To Longer Survival In Fatal Genetic Disorder
The FDA approved adrabetadex (Lembaz) injection on Tuesday for patients with infantile-onset Niemann-Pick disease type C (NPC), a rare and fatal genetic disorder. (Monaco, 11/18)
CIDRAP: People With Certain Herpes Infections Have Almost 50% Higher Risk Of Alzheimer’s Or Dementia, Review Finds
Being infected with herpes simplex virus type 1 (HSV-1) is associated with a 48% increase in the risk of Alzheimer’s disease or other types of dementia, according to a meta-analysis published this week in Open Forum Infectious Diseases. About two-thirds of people in the world under 50 are infected with HSV-1, which can cause cold sores and genital blisters. (Szabo, 11/17)
MedPage Today: Wegovy Reduces BMI In Kids With Obesity As Young As 6
Young children ages 6 to 11 years with obesity lost significant weight with the GLP-1 medication semaglutide (Wegovy), according to results from the phase III STEP Young trial. (Monaco, 11/16)
MedPage Today: How Impactful Is Stock Epinephrine For Anaphylaxis At Schools?
A survey of school nurses suggests failure with relying on students to carry autoinjectors. But stock epinephrine doesn't help if there are no school nurses or they don't feel comfortable administering it, one expert said. (Phend, 11/16)